Get the Stockscreener App
392.22
1.39%
-5.54
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $392.22, with a volume of 1.77M.
It is down -1.39% in the last 24 hours and up +7.62% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$397.76
Open:
$398.66
24h Volume:
1.77M
Relative Volume:
1.06
Market Cap:
$47.09B
Revenue:
$137.20B
Net Income/Loss:
$1.15B
P/E Ratio:
41.98
EPS:
9.3439
Net Cash Flow:
$1.27B
1W Performance:
-1.14%
1M Performance:
+7.62%
6M Performance:
+41.67%
1Y Performance:
+68.93%
1-Day Range:
$390.46
$398.66
1-Week Range:
$388.10
$405.05
52-Week Range:
$163.11
$415.00
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
392.22 | 47.09B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
424.62 | 385.62B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
104.15 | 132.89B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
416.23 | 90.39B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
293.46 | 77.63B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Is ELV's Capital Allocation Strategy Creating Long-Term Value? - TradingView
Can UNH's Lifestyle Spending Account Redefine Employee Benefits? - TradingView
Swedbank AB Has $15.21 Million Stock Position in Humana Inc. $HUM - MarketBeat
Humana Inc. (NYSE:HUM) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Humana (HUM) Stock Looks Fully Priced On Illinois Medicaid Win - Sahm
UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings? - TradingView
Humana Inc Profile: Recipients - OpenSecrets
Humana Inc outlook and business model as health insurance demand stays robust - AD HOC NEWS
Humana Earnings Preview: What to Expect - Yahoo Finance
Cantor Fitzgerald raises Humana stock price target on Medicaid data - Investing.com
Cantor Fitzgerald reiterates Neutral on Humana stock at $264 - Investing.com
Cantor Fitzgerald reiterates Neutral on Humana stock at $264 By Investing.com - Investing.com Canada
Humana Inc. (HUM) Stock Analysis: Navigating Market Dynamics with a 23.50% Revenue Growth in Healthcare Plans - DirectorsTalk Interviews
UNH, Humana, CVS Soar, and Wall Street Analysts Take NoteUnitedHealth Group (NYSE:UNH), Humana (NYSE:H - Benzinga
Law firm probes Humana officers for possible br... - Pluang
HUMHumana Inc Latest SEC Filings - Finviz
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Humana Inc. (HUM) And Encourages Shareholders to Connect - ACCESS Newswire
Humana (HUM) director Hilzinger granted 233 RSUs, holds 19,448 shares - Stock Titan
Humana Inc (HUM) Stock Down 3.1% but Still Overvalued -- GF Scor - GuruFocus
Humana Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Is Humana's (HUM) Loneliness Grants Strategy Hinting at a Deeper Medicare Advantage Narrative Shift? - simplywall.st
Humana Foundation awards $12M to combat loneliness among seniors - The Business Journals
Humana Inc (HUM) Shares Surge 3.1% -- What GF Score of 87 Tells Investors - GuruFocus
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana, Centene lead healthcare rally in Q2 over Medicare Advantage optimism - Seeking Alpha
The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants - Humana
How CenterWell Is Driving Humana's Growth Beyond Insurance - Zacks Investment Research
UnitedHealth, Humana and CVS Denied Post-Hospital Care At Some Of The Highest Rates - Neurology Advisor
2026-06-28 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Humana Inc. (HUM) and Encourages Shareholders to Learn More About the Investigation | NYSE:HUM | Press Release - Stockhouse
Humana Inc. Actuals & Estimates (NYSE:HUM) - TradingView
Humana Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Humana Inc. Actuals & Estimates (MUN:HUM) - TradingView
Humana stock hits 52-week high at 381.2 USD By Investing.com - Investing.com Nigeria
Humana stock hits 52-week high at 381.2 USD - Investing.com
Humana Inc. Actuals & Estimates (BMV:HUM) - TradingView
Humana Inc. (HUM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Humana Inc. Actuals & Estimates (XETR:HUM) - TradingView
Humana Inc. Actuals & Estimates (BIVA:HUM) - TradingView
Humana Inc.: - marketscreener.com
A Look at Humana Inc (HUM) After 4.0% Gain -- GF Value $362.88 v - GuruFocus
Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM) - Yahoo Finance
Price to sales forward of Humana Inc. – NYSE:HUM - TradingView
Humana Inc. $HUM Shares Sold by Leeward Investments LLC MA - MarketBeat
Price to earnings forward of Humana Inc. – NYSE:HUM - TradingView
Did Humana’s (HUM) Illinois Medicaid Win and MA Uncertainty Just Rebalance Its Risk Profile? - simplywall.st
UnitedHealth, Humana and CVS denied post-hospital care at some of the highest rates - Medical Xpress
Can Humana's Margin Recovery Drive Long-Term Earnings Growth? - The Globe and Mail
UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates - U.S. News & World Report
HUM News | HUMANA INC (NYSE:HUM) - ChartMill
Humana Inc. Stock 12‑Month Price Target Raised to $301.12, Implies 16% Downside - TradingView
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):